Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Jan;71(1):37–39. doi: 10.1038/bjc.1995.8

O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours.

S Egyházi 1, J Hansson 1, U Ringborg 1
PMCID: PMC2033437  PMID: 7819045

Abstract

Tumour samples obtained from one primary melanoma and several lymph node and skin metastases were analysed for O6-methylguanine-DNA methyltransferase (MGMT) activity. While lymph node and skin metastases had similar average MGMT activity, the variance was significantly higher in lymph node metastases. Variability in MGMT activity was frequently observed in different metastases in the same individual and to a lesser extent within metastases.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  2. Cao E. H., Fan X. J., Yuan X. H., Xin S. M., Liu Y. Y., Yu H. T. Levels of O6-methylguanine acceptor protein in extracts of human breast tumor tissues. Cancer Biochem Biophys. 1991 Jun;12(1):53–58. [PubMed] [Google Scholar]
  3. Citron M., Decker R., Chen S., Schneider S., Graver M., Kleynerman L., Kahn L. B., White A., Schoenhaus M., Yarosh D. O6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res. 1991 Aug 15;51(16):4131–4134. [PubMed] [Google Scholar]
  4. Comis R. L. DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep. 1976 Feb;60(2):165–176. [PubMed] [Google Scholar]
  5. Day R. S., 3rd, Ziolkowski C. H., Scudiero D. A., Meyer S. A., Lubiniecki A. S., Girardi A. J., Galloway S. M., Bynum G. D. Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature. 1980 Dec 25;288(5792):724–727. doi: 10.1038/288724a0. [DOI] [PubMed] [Google Scholar]
  6. Egyházi S., Bergh J., Hansson J., Karran P., Ringborg U. Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines. Eur J Cancer. 1991;27(12):1658–1662. doi: 10.1016/0277-5379(91)90440-o. [DOI] [PubMed] [Google Scholar]
  7. Erickson L. C., Bradley M. O., Ducore J. M., Ewig R. A., Kohn K. W. DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proc Natl Acad Sci U S A. 1980 Jan;77(1):467–471. doi: 10.1073/pnas.77.1.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fergusson R. J., Anderson L. E., Macpherson J. S., Robins P., Smyth J. F. Activity of a new nitrosourea (TCNU) in human lung cancer xenografts. Br J Cancer. 1988 Apr;57(4):339–342. doi: 10.1038/bjc.1988.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frosina G., Rossi O., Arena G., Gentile S. L., Bruzzone E., Abbondandolo A. O6-alkylguanine-DNA alkyltransferase activity in human brain tumors. Cancer Lett. 1990 Dec 3;55(2):153–158. doi: 10.1016/0304-3835(90)90026-t. [DOI] [PubMed] [Google Scholar]
  10. Karran P., Lindahl T., Griffin B. Adaptive response to alkylating agents involves alteration in situ of O6-methylguanine residues in DNA. Nature. 1979 Jul 5;280(5717):76–77. doi: 10.1038/280076a0. [DOI] [PubMed] [Google Scholar]
  11. Karran P., Moscona A., Strauss B. Developmental decline in DNA repair in neural retina cells of chick embryos. Persistent deficiency of repair competence in a cell line derived from late embryos. J Cell Biol. 1977 Jul;74(1):274–286. doi: 10.1083/jcb.74.1.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Karran P., Stephenson C., Macpherson P., Cairns-Smith S., Priestley A. Coregulation of the human O6-methylguanine-DNA methyltransferase with two unrelated genes that are closely linked. Cancer Res. 1990 Mar 1;50(5):1532–1537. [PubMed] [Google Scholar]
  13. Lee S. M., Rafferty J. A., Elder R. H., Fan C. Y., Bromley M., Harris M., Thatcher N., Potter P. M., Altermatt H. J., Perinat-Frey T. Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma. Br J Cancer. 1992 Aug;66(2):355–360. doi: 10.1038/bjc.1992.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Meer L., Janzer R. C., Kleihues P., Kolar G. F. In vivo metabolism and reaction with DNA of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC). Biochem Pharmacol. 1986 Oct 1;35(19):3243–3247. doi: 10.1016/0006-2952(86)90419-3. [DOI] [PubMed] [Google Scholar]
  15. Mineura K., Izumi I., Kuwahara N., Kowada M. O6-methylguanine-DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment? Acta Oncol. 1994;33(1):29–32. doi: 10.3109/02841869409098371. [DOI] [PubMed] [Google Scholar]
  16. Myrnes B., Giercksky K. E., Krokan H. Interindividual variation in the activity of O6-methyl guanine-DNA methyltransferase and uracil-DNA glycosylase in human organs. Carcinogenesis. 1983 Dec;4(12):1565–1568. doi: 10.1093/carcin/4.12.1565. [DOI] [PubMed] [Google Scholar]
  17. Myrnes B., Norstrand K., Giercksky K. E., Sjunneskog C., Krokan H. A simplified assay for O6-methylguanine-DNA methyltransferase activity and its application to human neoplastic and non-neoplastic tissues. Carcinogenesis. 1984 Aug;5(8):1061–1064. doi: 10.1093/carcin/5.8.1061. [DOI] [PubMed] [Google Scholar]
  18. Pegg A. E. Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 1990 Oct 1;50(19):6119–6129. [PubMed] [Google Scholar]
  19. Ringborg U., Jungnelius U., Hansson J., Strander H. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial. Am J Clin Oncol. 1990 Jun;13(3):214–217. doi: 10.1097/00000421-199006000-00007. [DOI] [PubMed] [Google Scholar]
  20. Ringborg U., Rudenstam C. M., Hansson J., Hafström L., Stenstam B., Strander H. Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study. Med Oncol Tumor Pharmacother. 1989;6(4):285–289. doi: 10.1007/BF02985163. [DOI] [PubMed] [Google Scholar]
  21. Scudiero D. A., Meyer S. A., Clatterbuck B. E., Mattern M. R., Ziolkowski C. H., Day R. S., 3rd Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res. 1984 Jun;44(6):2467–2474. [PubMed] [Google Scholar]
  22. Sklar R., Strauss B. Removal of O6-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid lines. Nature. 1981 Jan 29;289(5796):417–420. doi: 10.1038/289417a0. [DOI] [PubMed] [Google Scholar]
  23. Wiestler O., Kleihues P., Pegg A. E. O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis. 1984 Jan;5(1):121–124. doi: 10.1093/carcin/5.1.121. [DOI] [PubMed] [Google Scholar]
  24. Yarosh D. B., Foote R. S., Mitra S., Day R. S., 3rd Repair of O6-methylguanine in DNA by demethylation is lacking in Mer- human tumor cell strains. Carcinogenesis. 1983;4(2):199–205. doi: 10.1093/carcin/4.2.199. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES